Monday, November 5, 2018
NinePoint Medical announces FDA clearance of NvisionVLE Imaging System
NinePoint Medical announced that it has received FDA clearance to market its Intelligent Real-time Image Segmentation software upgrade for its flagship product, the NvisionVLE Imaging System. IRIS, an artificial intelligence-based platform for image feature segmentation, is the first tool of its kind approved for use in imaging of esophageal tissue. The clearance of IRIS marks the first product addition to the NvisionVLE Imaging System family since NinePoint Medical began a strategic collaboration with its worldwide distributor, Merit Medical Systems.
https://thefly.com/landingPageNews.php?id=2817331
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.